Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasonex for Seasonal Allergic Rhinitis
NCT00728416Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Organon & Co.. Started Aug 2008; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00728416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728416.